Infectious Disease Archives | サターラ

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025年10月31日

Conference

ICAComP 2025

Certara2025年10月8日

On-Demand Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

Certara2025年6月18日

Publication

Advancing pharmacometrics in Africa – Transition from capacity development toward job creation

This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…

Certara2024年12月9日

ポスター

Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis.

Certara2024年11月22日

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Certara2020年1月17日

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Certara2020年1月17日

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

Certara2019年6月24日

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

Certara2019年6月24日

Publication

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

Certara2018年7月1日

© 2025 Certara. All Rights Reserved. | 法務関連 | 個人情報保護

Powered by Translations.com GlobalLink Web Software